BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38697175)

  • 1. Rare and severe adverse events in children with inflammatory bowel disease: analysis of data from the PIBD-SETQuality Safety Registry.
    Klomberg RCW; Hellendoorn AE; Kemos P; Rizopoulos D; Ruemmele FM; Croft NM; de Ridder L;
    Lancet Child Adolesc Health; 2024 Jun; 8(6):422-432. PubMed ID: 38697175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Incidence and Characteristics of Venous Thromboembolisms in Paediatric-Onset Inflammatory Bowel Disease: A Prospective International Cohort Study Based on the PIBD-SETQuality Safety Registry.
    Aardoom MA; Klomberg RCW; Kemos P; Ruemmele FM; ; van Ommen CHH; de Ridder L; Croft NM;
    J Crohns Colitis; 2022 Jun; 16(5):695-707. PubMed ID: 34599822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International prospective observational study investigating the disease course and heterogeneity of paediatric-onset inflammatory bowel disease: the protocol of the PIBD-SETQuality inception cohort study.
    Aardoom MA; Kemos P; Tindemans I; Aloi M; Koletzko S; Levine A; Turner D; Veereman G; Neyt M; Russell RK; Walters TD; Ruemmele FM; Samsom JN; Croft NM; de Ridder L;
    BMJ Open; 2020 Jul; 10(7):e035538. PubMed ID: 32611739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corona Virus Disease 2019 and Paediatric Inflammatory Bowel Diseases: Global Experience and Provisional Guidance (March 2020) from the Paediatric IBD Porto Group of European Society of Paediatric Gastroenterology, Hepatology, and Nutrition.
    Turner D; Huang Y; Martín-de-Carpi J; Aloi M; Focht G; Kang B; Zhou Y; Sanchez C; Kappelman MD; Uhlig HH; Pujol-Muncunill G; Ledder O; Lionetti P; Dias JA; Ruemmele FM; Russell RK;
    J Pediatr Gastroenterol Nutr; 2020 Jun; 70(6):727-733. PubMed ID: 32443020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory Bowel Disease Incidence is on the Continuous Rise Among All Paediatric Patients Except for the Very Young: A Nationwide Registry-based Study on 28-Year Follow-up.
    Virta LJ; Saarinen MM; Kolho KL
    J Crohns Colitis; 2017 Feb; 11(2):150-156. PubMed ID: 27555642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Italian Cystic Fibrosis Registry (ICFR). Report 2021-2022].
    Campagna G; Amato A; Majo F; Ferrari G; Quattrucci S; Padoan R; Floridia G; Salvatore D; Carnovale V; Puppo Fornaro G; Taruscio D; Salvatore M;
    Epidemiol Prev; 2024; 48(2 Suppl 2):1-41. PubMed ID: 38742380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How can patient registries facilitate guideline-based healthcare? A retrospective analysis of the CEDATA-GPGE registry for pediatric inflammatory bowel disease.
    Leiz M; Knorr M; Moon K; Tischler L; Sohrabi K; Cantez S; Däbritz J; de Laffolie J; van den Berg N;
    BMC Health Serv Res; 2023 Jun; 23(1):648. PubMed ID: 37330476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic workup of paediatric patients with inflammatory bowel disease in Europe: results of a 5-year audit of the EUROKIDS registry.
    de Bie CI; Buderus S; Sandhu BK; de Ridder L; Paerregaard A; Veres G; Dias JA; Escher JC;
    J Pediatr Gastroenterol Nutr; 2012 Mar; 54(3):374-80. PubMed ID: 21857248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective Incidence of Paediatric Inflammatory Bowel Disease in New Zealand in 2015: Results From the Paediatric Inflammatory Bowel Disease in New Zealand (PINZ) Study.
    Lopez RN; Evans HM; Appleton L; Bishop J; Chin S; Mouat S; Gearry RB; Day AS
    J Pediatr Gastroenterol Nutr; 2018 May; 66(5):e122-e126. PubMed ID: 29077643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vedolizumab in Paediatric Inflammatory Bowel Disease: A Retrospective Multi-Centre Experience From the Paediatric IBD Porto Group of ESPGHAN.
    Ledder O; Assa A; Levine A; Escher JC; de Ridder L; Ruemmele F; Shah N; Shaoul R; Wolters VM; Rodrigues A; Uhlig HH; Posovszky C; Kolho KL; Jakobsen C; Cohen S; Shouval DS; de Meij T; Martin-de-Carpi J; Richmond L; Bronsky J; Friedman M; Turner D
    J Crohns Colitis; 2017 Oct; 11(10):1230-1237. PubMed ID: 28605483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Cancer in Paediatric onset Inflammatory Bowel Diseases: A Nation-wide Study From the epi-IIRN.
    Atia O; Harel S; Ledderman N; Greenfeld S; Kariv R; Dotan I; Balicer R; Silverman B; Matz E; Levi Z; Waterman M; Fried I; Rowe JM; Turner D
    J Crohns Colitis; 2022 Jun; 16(5):786-795. PubMed ID: 34791097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The complete picture of changing pediatric inflammatory bowel disease incidence in Spain in 25 years (1985-2009): the EXPERIENCE registry.
    Martín-de-Carpi J; Rodríguez A; Ramos E; Jiménez S; Martínez-Gómez MJ; Medina E; Navas-López VM;
    J Crohns Colitis; 2014 Aug; 8(8):763-9. PubMed ID: 24462789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infliximab in young paediatric IBD patients: it is all about the dosing.
    Jongsma MME; Winter DA; Huynh HQ; Norsa L; Hussey S; Kolho KL; Bronsky J; Assa A; Cohen S; Lev-Tzion R; Van Biervliet S; Rizopoulos D; de Meij TGJ; Shouval DS; Wine E; Wolters VM; Martinez-Vinson C; de Ridder L;
    Eur J Pediatr; 2020 Dec; 179(12):1935-1944. PubMed ID: 32813123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes, dosing, and predictors of vedolizumab treatment in children with inflammatory bowel disease (VEDOKIDS): a prospective, multicentre cohort study.
    Atia O; Shavit-Brunschwig Z; Mould DR; Stein R; Matar M; Aloi M; Ledder O; Focht G; Urlep D; Hyams J; Broide E; Weiss B; Levine J; Russell RK; Turner D
    Lancet Gastroenterol Hepatol; 2023 Jan; 8(1):31-42. PubMed ID: 36306803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.
    Sinopoulou V; Gordon M; Akobeng AK; Gasparetto M; Sammaan M; Vasiliou J; Dovey TM
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013531. PubMed ID: 34844288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of tumour necrosis factor-α inhibitors and the risk of serious infection in paediatric inflammatory bowel disease in Denmark: a nationwide cohort study.
    Wintzell V; Svanström H; Melbye M; Jess T; Olén O; Ludvigsson JF; Pasternak B
    Lancet Gastroenterol Hepatol; 2019 Nov; 4(11):845-853. PubMed ID: 31494100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and projected incidence trends of pediatric-onset inflammatory bowel disease in Germany based on the Saxon Pediatric IBD Registry 2000-2014 -a 15-year evaluation of trends.
    Kern I; Schoffer O; Richter T; Kiess W; Flemming G; Winkler U; Quietzsch J; Wenzel O; Zurek M; Manuwald U; Hegewald J; Li S; Weidner J; de Laffolie J; Zimmer KP; Kugler J; Laass MW; Rothe U
    PLoS One; 2022; 17(9):e0274117. PubMed ID: 36084003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.